Factor | Crude OR | 95%CI | Adjusted OR | 95%CI | p-value |
---|---|---|---|---|---|
Gender | |||||
Female | 1.00 (reference) | 1.00 (reference) | |||
Male | 1.47 | 0.85–2.54 | 1.47 | 0.80–2.70 | 0.22 |
Education level | |||||
Undergraduate (Bachelor) | 1.00 (reference) | 1.00 (reference) | |||
Graduate (Master or PhD) | 1.14 | 0.61–2.13 | 1.37 | 0.69–2.72 | 0.38 |
Study background | |||||
Health sciences | 1.00 (reference) | 1.00 (reference) | |||
Non-health sciences | 1.087 | 0.59–2.00 | 1.159 | 0.62–2.18 | 0.65 |
School or job mandate | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 1.57 | 0.77–3.18 | 1.43 | 0.66–3.10 | 0.37 |
Vaccine accessibility | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 3.35 | 1.51–7.47 | 2.77 | 1.10–6.97 | 0.03a |
Side effects | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 1.13 | 0.43–2.91 | 0.61 | 0.26–2.17 | 0.52 |
Product safety | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 2.86 | 0.55–14.95 | 2.95 | 0.36–24.46 | 0.61 |
Vaccine costs | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 1.89 | 1.04–3.45 | 1.53 | 0.78–3.03 | 0.21 |
COVID-19 infection history or close contact with COVID-19 patients | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 1.27 | 0.66–2.47 | 0.82 | 0.42–1.99 | 0.82 |
Social responsibility | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 1.29 | 0.46–3.66 | 0.96 | 0.26–3.59 | 0.96 |
Scientific evidence | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 1.67 | 0.69–4.03 | 1.57 | 0.55–4.39 | 0.40 |
Efficacy | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 1.12 | 0.22–5.64 | 0.62 | 0.08–5.55 | 0.67 |
Future career requirements | |||||
No | 1.00 (reference) | 1.00 (reference) | |||
Yes | 0.80 | 0.31–2.05 | 0.48 | 0.15–1.52 | 0.21 |